BA
REGN icon

BlackRock Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$131M Sell
356,866
-245,615
-41% -$93.4M 0.13% 166
2016
Q3 		$242M Buy
602,481
+183,538
+44% +$73.6M 0.25% 100
2016
Q2 		$146M Buy
418,943
+227,998
+119% +$87.8M 0.15% 157
2016
Q1 		$68.8M Sell
190,945
-71,521
-27% -$29.5M 0.07% 262
2015
Q4 		$142M Buy
262,466
+20,224
+8% +$11M 0.15% 152
2015
Q3 		$113M Sell
242,242
-17,697
-7% -$9.5M 0.12% 182
2015
Q2 		$133M Sell
259,939
-172,728
-40% -$84.3M 0.14% 162
2015
Q1 		$195M Sell
432,667
-120,098
-22% -$50.9M 0.2% 129
2014
Q4 		$227M Sell
552,765
-205,344
-27% -$80.8M 0.23% 114
2014
Q3 		$273M Sell
758,109
-177,228
-19% -$59.4M 0.27% 91
2014
Q2 		$264M Buy
935,337
+356,403
+62% +$106M 0.25% 103
2014
Q1 		$174M Sell
578,934
-104,139
-15% -$32.1M 0.17% 149
2013
Q4 		$188M Buy
683,073
+44,159
+7% +$12.7M 0.18% 144
2013
Q3 		$200M Buy
638,914
+311,756
+95% +$82M 0.2% 134
2013
Q2 		$73.6M Buy
+327,158
New +$76.2M 0.08% 253

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock Advisors's REGN Position: Q4 2016 in Review

BlackRock Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 41% in Q4 2016, selling an estimated $93.4M and leaving 356,866 shares worth $131M. The position accounts for 0.13% of the portfolio, ranked #166.

BlackRock Advisors first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $273M in Q3 2014. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Advisors held 356,866 shares of Regeneron Pharmaceuticals worth $131M as of Q4 2016.
  • BlackRock Advisors sold 245,615 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $93.4M.
  • Regeneron Pharmaceuticals made up 0.13% of BlackRock Advisors's portfolio in Q4 2016, its #166 holding.
  • BlackRock Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Regeneron Pharmaceuticals position peaked at $273M in Q3 2014.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.